Targeted Therapies: The Rare Cancer Paradigm
To access this article, please choose from the options below
PII: S1574-7891(09)00131-8
doi:10.1016/j.molonc.2009.10.003
© 2009 Federation of European Biochemical Societies. Published by Elsevier Inc. All rights reserved.

